Health Research - Weekly News

Health Research - Weekly News


1) Canadian Institutes of Health Research (CIHR):   a) Updates for the CIHR ResearchNet e-Approval Process   b) Results of the March 2011 Operating Grants Competition   c) Funding decisions for the March 2011 Operating Grants competition are now available   d) Clinical Interventions for Cardiovascular Disease: Enhancing Effectiveness   The information included in this email message is also posted at the following URL:
~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ *   1) Canadian Institutes of Health Research (CIHR):   a) Updates for the CIHR ResearchNet e-Approval Process  

This memo is to advise you that in addition to CIHR’s Open Operating Grants program, five additional CIHR grant programs have been added to the e-Approval process. 

These programs are:


·         Proof of Principle Program - Phase I

·         Proof of Principle Program - Phase II

·         Knowledge Synthesis Grant

·         Partnerships for Health System Improvement (PHSI)

·         Randomized Controlled Trials: Mentoring


Researchers must submit their applications electronically via ResearchNet by 8 PM EST to the Office of Research Services (ORS) for compliance review and Institutional approval (a hard copy with all required by CIHR and UofR signatures to be dropped off before or on this date), by an internal deadline:


August 25, 2011             Proof of Principle Program - Phase I (September 1st 2011 competition)

August 25, 2011             Proof of Principle Program - Phase II (September 1st 2011 competition)

September 13, 2011       Operating Grant (September 15th 2011 competition)

September 26, 2011       Knowledge Synthesis Grant (October 3rd 2011 competition)

5 business days prior      Partnerships for Health System Improvement (PHSI) (competition: TBA)

5 business days prior      Randomized Controlled Trials: Mentoring (competition: TBA)


Once the applications are approved, ORS will be submitting the applications electronically to CIHR on behalf of the applicant. ORS will not be able to change any information in the application but can return the application to the applicant with their suggestions for improvements. 


If you require assistance with a proposal development, please contact ORS.


Note:  Registration for September 2011 CIHR Operating Grant competition is now open in ResearchNet.

~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * b) Results of the March 2011 Operating Grants Competition  

On behalf of CIHR, I am pleased to announce the results of the spring 2011 Open Operating Grants competition,, in which CIHR approved the investment of $240.2 million over five years. As with previous competitions, we met our on-going commitment to the research community to fund at least 400 grants from the core competition budget and to maintain or increase the average value of these grants. In addition approximately 60 full term and bridge grants are expected to be funded through Priority Announcements and other sources for a total of 460 grants approved from the Operating Grant 2010-2011 (March) competition. The average (mean) annual core competition grant size was $600,470 (median grant size of $592,298) with an average duration of 4.19 years.


As with the Results of the March 2010 Open Operating Grants Competition,, the March 2011 competition marked the second time that the Open Operating Grants competition dedicated a part of the Open Operating Grants budget to a specific funding envelope - worth approximately $12.5 million - for large grants, including large RCTs. Three large grants with an average total grant size of $4.1M were funded in this competition. Applications that were within the top 0.5% of peer review committee recommended average annual budgets were ranked together and funded from the top down within the available funding envelope. Other facts and frequently asked questions relating to the Open Operating Grant Program are available on the CIHR website, in the document CIHR Open Operating Grant Program, Competitions Frequently Asked Questions,


The results of this funding competition represent positive news for the research community and for all Canadians – the people who will ultimately benefit from the results of the research we fund. 


Looking ahead, it seems clear that we will continue to be challenged by our own success in building a vibrant, creative and highly competitive health research community. We do have some concerns about the funding process. We know that a tremendous amount of effort is required to prepare an application. We also appreciate the many months of work dedicated by over 860 reviewers to evaluate these applications. The increase in number of applications – especially in those that are essentially resubmissions of unsuccessful applications – represents a growing concern for our peer reviewers. Consequently, we intend to ask researchers to submit only their most competitive applications. Conversely, we discourage researchers from immediately resubmitting unsuccessful applications to the next competition with no change or reflection. As well, we suggest that after an application has been unsuccessful 2 or 3 times that it not be resubmitted.


We encourage these voluntary measures in the hope that the research community and the institutions that CIHR supports will work with us to manage the volume of work required by your peers to review and rank applications.


I wish to congratulate the recipients of March 2011 Open Operating Grants and wish them success in all their research endeavours.


Kelly VanKoughnet

Acting Chief Scientific Officer and Vice-President, Research

Canadian Institutes of Health Research


~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ *


c) Funding decisions for the March 2011 Operating Grants competition are now available


Refer to


~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ *


d) Clinical Interventions for Cardiovascular Disease: Enhancing Effectiveness

Competition: 201110KAL 
Application Deadline: 2011-10-03   
Anticipated Notice of Decision: 2012-04-02   
Funding Start Date: 2012-04-01

The CIHR Institute of Gender and Health's (IGH) Clinical Interventions for Cardiovascular Disease (CVD) initiative addresses the need for clinical interventions that are accessible, appropriate and effective with respect to sex and gender. CVD (including coronary artery disease, angina, congestive heart failure, hypertension and stroke) is the major cause of death and disability worldwide. Taking account of sex and gender has the potential to improve strategies for preventing, detecting and treating CVD. There is therefore a need to find ways to mobilize ready-to-implement evidence about sex and gender in the prevention, diagnosis and treatment of CVD to improve clinical practices.

IGH will provide funding for successful applications that are determined to be relevant to one or more of the following priority areas:
o Bridge a knowledge-to-action gap specific to gender, sex and clinical interventions for CVD.
o Accelerate the uptake of gender, sex and CVD research evidence into clinical practice.
o Enhance the effectiveness of clinical interventions for CVD by taking sex and gender into account.

For more information on IGH's strategic research direction on clinical interventions: enhancing effectiveness, please see IGH's Strategic Plan 2009-2012:

Funds Available
• The total amount available for this funding opportunity is $ 600,000. This amount may increase if additional funding partners decide to participate.
• The maximum amount awarded for a single grant is $ 100 000 per annum for up to two (2) years.

Specific Requirements
• This Priority Announcement will require the completion of a Relevance Form.
• Applicants are strongly encouraged to align their relevance form with their one-page project summary. The relevance form and one-page project summaries must clearly articulate how the concepts of gender and/or sex are integrated into the respective research designs and approaches. It is not sufficient simply to cite literature explaining why a study relates to gender and/or sex; these concepts must be substantively integrated into the research design. For more information on integrating gender and/or sex into research designs, please refer to the CIHR Gender, Sex and Health Research Guide:


~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ *

Subscription Information

Please feel free to distribute copies of this bulletin. If your e-mail address is changing, or you want to discontinue your subscription to the weekly health e-alerts, please visit the ORS website:   ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ * ~ *   Sarah Savage, PMP
Health Research Facilitator
Office of Research Services,
Research and Innovation Centre, Rm 109
University of Regina
Regina, Saskatchewan, Canada S4S 0A2
Phone: (306) 337.2479; Fax: (306) 585.4893